News | May 12, 2026
Plus Therapeutics subsidiary clears key Medicare milestone
Paves way for CNS cancer test rollout
Paves way for CNS cancer test rollout
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Digital platform records over 1.34 crore beneficiary registrations with QR-enabled MCH cards and real-time monitoring features
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
Subscribe To Our Newsletter & Stay Updated
